347 research outputs found

    KOMBINIRANO DJELOVANJE BITURATA I EKSTRAKTA YUCCA SCHIDIGERI NA GASTROINTESTINALNI SUSTAV SVINJA OKO ODBIJANJA

    Get PDF
    After the banning of antibiotics as growth promoters, animal production in the EU faced the problem of increased post-weaning disorders, and several solutions were proposed (acidifiers, probiotics, herb extracts, enzyme cocktails, etc.). Short chain fatty acids (SCFA) are the main end product of bacterial fermentation in the hind gut in monogastric animals and can be used as energy supply for the epithelial cells of gut mucosa. Thus the aim of the study was to test the usefulness of novel microencapsulated sodium butyrate and Yucca Schidigera extract (encourages friendly bacteria growth, reduces ammonia) preparation on pig performance and small intestine development in the critical weaning period. Microencapsulation helps to avoid stomach degradation and provides better distribution of the compounds along the small intestine. Suckling piglets, 14-day old, were divided into 2 groups, control and with butyrate addition. Control pigs received a standard feed supplemented with a microencapsulated acidifier (0.3%). Butyrate pigs received the same feed and acidifier, as controls, supplemented with butyrate/yucca preparation (0.3%). At days 28 (weaning), 35 and 56 of life, 6 pigs from each group were killed and the gastrointestinal tract was harvested and measured. The initial body weight (14 d) of pigs from the control group was higher than that of the experimental, but at day 56 it did not differ significantly (P=0.48). The relative stomach and pancreas weights in the experimental group showed a tendency toward higher values in all time points, and the small intestine relative weight in day 35 was higher as compared to the controls. The growth rate of the pigs at day 35 decreased significantly in the control (P=0.007), but did not in the experimental (P=0.058) group compared to day 31. Measurements of the small intestine sections revealed increased mucosa thickness in butyrate treated pigs. This was due to both villi and crypt enlargement. In conclusion, our results demonstrated the effectiveness sodium butyrate and Yucca Shidigera extract in the prevention of weaning problems in pigs, however further research on the novel preparation is needed.Nakon zabrane antibiotika kao promotora rasta, proizvodnja životinja u EU suočila se sa sve viÅ”e poremećaja nakon odbijanja pa je predloženo nekoliko rjeÅ”enja (acidifikatori, probiotici, biljni ekstrakti, kokteli enzima, itd.). Kratkolančane masne kiseline glavni su krajnji proizvod bakterijske fermentacije u stražnjem crijevu u monogastričnih životinja pa se mogu upotrijebiti za snabdijevanje energijom epitelnih stanica crijevne sluznice /mukoze. Stoga je cilj ovog rada bio testirati korisnost novog natrijevog biturata u mikrokapsuli i pripravka ekstrakta Yucca Schidigera (potiče rast dobročudnih bakterija, smanjuje amonijak) na performansu svinja i razvoj tankog crijeva u kritičnom razdoblju odbijanja. Mikrokapsule pomažu da se izbjegne oÅ”tećenje želuca i pruža bolju razdiobu spojeva duž tankog crijeva. PraŔčići na sisi, u dobi od 14 dana, bili su podijeljeni u dvije skupine, kontrolnu i skupinu s dodavanjem biturata. Kontrolni praŔčići dobivali su standardnu hranu s dodatkom acidifikatora/zakiseljivača u mikrokapsuli (0.03%). PraŔčići na bituratima dobivali su istu hranu i acidifikator/zakiseljivač s dodatkom biturata/yucca pripravka (0.03%). U dobi od 28 (odbijanje), 35 i 56 dana žrtvovano je 6 svinja iz svake skupine te je pregledan i izmjeren gastrointestinalni sustav. Početna tjelesna masa (14. dan) svinja iz kontrolne skupine bila je veća od mase svinja pokusne skupine ali 56. dan nije se značajno razlikovala (P=0.48). Relativne mase želuca i guÅ”terače u pokusnoj skupini pokazale su tendenciju viÅ”ih vrijednosti u svim razdobljima, a relativna masa tankog crijeva 35. dana bila je viÅ”a u usporedbi s kontrolnom skupinom. Stopa rasta svinja 35. dana znatno se smanjila u kontrolnoj skupini (P=0.007) ali ne u kontrolnoj skupini (P=0.058) u usporedbi s 31. danom. Mjere tankog crijeva pokazale su povećanu debljinu sluznice u svinja tretiranih bituratom. To se pripisuje povećanju dlačica i udubina (villi i crypt). U zaključku, naÅ”i su rezultati pokazali djelotvornost natrijevog biturata i ekstrakta Yucca Schidigeri u prevenciji problema odbijanja u svinja, međutim, potrebna su dalja istraživanja novih pripravaka

    Multifunctional platform based on electrospun nanofibers and plasmonic hydrogel. A smart nanostructured pillow for near-infrared light-driven biomedical applications

    Get PDF
    Multifunctional nanomaterials with the ability to respond to near-infrared (NIR) light stimulation are vital for the development of highly efficient biomedical nanoplatforms with a polytherapeutic approach. Inspired by the mesoglea structure of jellyfish bells, a biomimetic multifunctional nanostructured pillow with fast photothermal responsiveness for NIR light-controlled on-demand drug delivery is developed. We fabricate a nanoplatform with several hierarchical levels designed to generate a series of controlled, rapid, and reversible cascade-like structural changes upon NIR light irradiation. The mechanical contraction of the nanostructured platform, resulting from the increase of temperature to 42 Ā°C due to plasmonic hydrogel-light interaction, causes a rapid expulsion of water from the inner structure, passing through an electrospun membrane anchored onto the hydrogel core. The mutual effects of the rise in temperature and water flow stimulate the release of molecules from the nanofibers. To expand the potential applications of the biomimetic platform, the photothermal responsiveness to reach the typical temperature level for performing photothermal therapy (PTT) is designed. The on-demand drug model penetration into pig tissue demonstrates the efficiency of the nanostructured platform in the rapid and controlled release of molecules, while the high biocompatibility confirms the pillow potential for biomedical applications based on the NIR light-driven multitherapy strategy

    Measurement of event-by-event transverse momentum and multiplicity fluctuations using strongly intensive measures Ī”[PT,N]\Delta[P_T, N] and Ī£[PT,N]\Sigma[P_T, N] in nucleus-nucleus collisions at the CERN Super Proton Synchrotron

    Full text link
    Results from the NA49 experiment at the CERN SPS are presented on event-by-event transverse momentum and multiplicity fluctuations of charged particles, produced at forward rapidities in central Pb+Pb interactions at beam momenta 20AA, 30AA, 40AA, 80AA, and 158AA GeV/c, as well as in systems of different size (p+pp+p, C+C, Si+Si, and Pb+Pb) at 158AA GeV/c. This publication extends the previous NA49 measurements of the strongly intensive measure Ī¦pT\Phi_{p_T} by a study of the recently proposed strongly intensive measures of fluctuations Ī”[PT,N]\Delta[P_T, N] and Ī£[PT,N]\Sigma[P_T, N]. In the explored kinematic region transverse momentum and multiplicity fluctuations show no significant energy dependence in the SPS energy range. However, a remarkable system size dependence is observed for both Ī”[PT,N]\Delta[P_T, N] and Ī£[PT,N]\Sigma[P_T, N], with the largest values measured in peripheral Pb+Pb interactions. The results are compared with NA61/SHINE measurements in p+pp+p collisions, as well as with predictions of the UrQMD and EPOS models.Comment: 12 pages, 14 figures, to be submitted to PR

    Antideuteron and deuteron production in mid-central Pb+Pb collisions at 158AA GeV

    Get PDF
    Production of deuterons and antideuterons was studied by the NA49 experiment in the 23.5% most central Pb+Pb collisions at the top SPS energy of sNN\sqrt{s_{NN}}=17.3 GeV. Invariant yields for dĖ‰\bar{d} and dd were measured as a function of centrality in the center-of-mass rapidity range āˆ’1.2<y<āˆ’0.6-1.2<y<-0.6. Results for dĖ‰(d)\bar{d}(d) together with previously published pĖ‰(p)\bar{p}(p) measurements are discussed in the context of the coalescence model. The coalescence parameters B2B_2 were deduced as a function of transverse momentum ptp_t and collision centrality.Comment: 9 figure

    Phase I/II Trial of Liver-derived Mesenchymal Stem Cells in Pediatric Liver-based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Heterologous Human Adult Liver-derived Progenitor Cells (HepaStem) in Urea Cycle Disorders and Crigler-Najjar Syndrome Patients

    Get PDF
    Background. Regenerative medicine using stem cell technology is an emerging field that is currently tested for inborn and acquired liver diseases. Objective. This phase I/II prospective, open label, multicenter, randomized trial aimed primarily at evaluating the safety of Heterologous Human Adult Liverā€“derived Progenitor Cells (HepaStem) in pediatric patients with urea cycle disorders (UCDs) or Crigler-Najjar (CN) syndrome 6 months posttransplantation. The secondary objective included the assessment of safety up to 12 months postinfusion and of preliminary efficacy. Methods. Fourteen patients with UCDs and 6 with CN syndrome were divided into 3 cohorts by body weight and intraportally infused with 3 doses of HepaStem. Clinical status, portal vein hemodynamics, morphology of the liver, de novo detection of circulating antiā€“human leukocyte antigen antibodies, and clinically significant adverse events (AEs) and serious adverse events to infusion were evaluated by using an intent-to-treat analysis. Results. The overall safety of HepaStem was confirmed. For the entire study period, patient-month incidence rate was 1.76 for the AEs and 0.21 for the serious adverse events, of which 38% occurred within 1 month postinfusion. There was a trend of higher events in UCD as compared with CN patients. Segmental left portal vein thrombosis occurred in 1 patient and intraluminal local transient thrombus in a second patient. The other AEs were in line with expectations for catheter placement, cell infusion, concomitant medications, age, and underlying diseases. Conclusions. This study led to European clinical trial authorization for a phase II study in a homogeneous patient cohort, with repeated infusions and intermediate doses

    Confronting the Challenge of Modeling Cloud and Precipitation Microphysics

    Get PDF
    In the atmosphere, microphysics refers to the microscale processes that affect cloud and precipitation particles and is a key linkage among the various components of Earth\u27s atmospheric water and energy cycles. The representation of microphysical processes in models continues to pose a major challenge leading to uncertainty in numerical weather forecasts and climate simulations. In this paper, the problem of treating microphysics in models is divided into two parts: (i) how to represent the population of cloud and precipitation particles, given the impossibility of simulating all particles individually within a cloud, and (ii) uncertainties in the microphysical process rates owing to fundamental gaps in knowledge of cloud physics. The recently developed Lagrangian particleā€based method is advocated as a way to address several conceptual and practical challenges of representing particle populations using traditional bulk and bin microphysics parameterization schemes. For addressing critical gaps in cloud physics knowledge, sustained investment for observational advances from laboratory experiments, new probe development, and nextā€generation instruments in space is needed. Greater emphasis on laboratory work, which has apparently declined over the past several decades relative to other areas of cloud physics research, is argued to be an essential ingredient for improving processā€level understanding. More systematic use of natural cloud and precipitation observations to constrain microphysics schemes is also advocated. Because it is generally difficult to quantify individual microphysical process rates from these observations directly, this presents an inverse problem that can be viewed from the standpoint of Bayesian statistics. Following this idea, a probabilistic framework is proposed that combines elements from statistical and physical modeling. Besides providing rigorous constraint of schemes, there is an added benefit of quantifying uncertainty systematically. Finally, a broader hierarchical approach is proposed to accelerate improvements in microphysics schemes, leveraging the advances described in this paper related to process modeling (using Lagrangian particleā€based schemes), laboratory experimentation, cloud and precipitation observations, and statistical methods
    • ā€¦
    corecore